| Serum level and tissue expression of c-erbB-1 and c-erbB-2 proto-oncogene products in patients with squamous cell carcinoma of the head and neck. | HNSC, |
| Immunoelectron microscopical identification of the c-erbB-2 oncoprotein in patients with laryngeal squamous cell carcinoma. | laryngeal, |
| Effect of melatonin and linolenic acid on mammary cancer in transgenic mice with c-neu breast cancer oncogene. | breast, |
| Prognostic impact of cathepsin D and c-erbB-2 oncoprotein in a subgroup of node-negative breast cancer patients with low histological grade tumors. | breast, |
| Multisite phosphotyping of the ErbB-2 oncoprotein in human breast cancer. | breast, |
| [Oncogene her-2/neu and ovarian carcinoma: intraperitoneal cellular immunotherapy]. | ovarian, |
| HER-2/neu oncogene expression in advanced breast cancer. | breast, |
| Marked Intratumoral Heterogeneity of the Proto-Oncogene Her-2/neu Determined by Three Different Detection Systems. | oral |
| C-erbB-2 oncoprotein overexpression identifies a subgroup of estrogen receptor positive (ER+) breast cancer patients with poor prognosis. | breast, |
| Expression of HER-2/NEU oncoprotein in familial and non-familial breast cancer. | breast, |
| Oncoprotein c-erbB-2 in squamous cell carcinoma of the uterine cervix and evaluation of its significance in response of disease to treatment. | uterine, |
| HER-2/neu overexpression in breast cancer: an immunohistochemical study including correlations with clinicopathologic parameters, p53 oncoprotein and cathepsin-D. | breast, |
| Amplification of the HER-2/neu oncogene is uncommon in pediatric osteosarcomas. | osteosarcoma,pediatric, |
| Oncogenic potential of c-erbB-2 and its association with c-K-ras in premalignant and malignant lesions of the human uterine endometrium. | uterine, |
| Investigation of the c-neu proto-oncogene related protein, p185, in the serum of primary epithelial ovarian cancer patients. | ovarian, |
| Amplification of HER-2/neu oncogene in human ovarian cancer. | ovarian, |
| Expression of HER-2/neu oncoprotein, DNA-ploidy and S-phase fraction in advanced ovarian cancer. | ovarian, |
| The expression of c-erbB-2 (HER-2/neu) oncogene in invasive ovarian malignancies. | ovarian, |
| [Quantitative detection of HER-2 oncogene amplification in primary hepatocellular carcinoma using dual FISH technique and its clinical significance]. | liver, |
| Overexpression of the HER-2/neu oncogene in pancreatic adenocarcinoma. | pancreatic, |